These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Troglitazone: a new class of oral antihyperglycemic for the treatment of type II diabetes. Teter ML Nurse Pract; 1997 Jul; 22(7):119-21. PubMed ID: 9253019 [No Abstract] [Full Text] [Related]
4. Pharmacologic management of diabetes mellitus. Mozersky RP J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525 [TBL] [Abstract][Full Text] [Related]
6. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus. Johnson MD; Campbell LK; Campbell RK Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065 [TBL] [Abstract][Full Text] [Related]
14. Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study. Stakos DA; Schuster DP; Sparks EA; Wooley CF; Osei K; Boudoulas H J Cardiol; 2003 Apr; 41(4):183-90. PubMed ID: 12728539 [TBL] [Abstract][Full Text] [Related]
15. Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus. Parker JC Adv Drug Deliv Rev; 2002 Nov; 54(9):1173-97. PubMed ID: 12393300 [TBL] [Abstract][Full Text] [Related]
16. American Diabetes Association Annual Meeting, 1997. Type 2 diabetes. Bloomgarden ZT Diabetes Care; 1997 Nov; 20(11):1791-5. PubMed ID: 9353625 [No Abstract] [Full Text] [Related]
17. A potential solution for the shortage of donors in islet transplantation using a novel oral antidiabetic agent, troglitazone. Nagai T; Yasunami Y; Nagata N; Ryu S; Ono J; Ikeda S Transplant Proc; 1995 Dec; 27(6):3405. PubMed ID: 8540020 [No Abstract] [Full Text] [Related]
18. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. Inzucchi SE; Maggs DG; Spollett GR; Page SL; Rife FS; Walton V; Shulman GI N Engl J Med; 1998 Mar; 338(13):867-72. PubMed ID: 9516221 [TBL] [Abstract][Full Text] [Related]
19. How should patients taking the discontinued diabetes drug troglitazone be managed? Reddy SS Cleve Clin J Med; 2000 Jun; 67(6):401-2, 455. PubMed ID: 10860221 [No Abstract] [Full Text] [Related]
20. Troglitazone directly inhibits CO(2) production from glucose and palmitate in isolated rat skeletal muscle. Fürnsinn C; Brunmair B; Neschen S; Roden M; Waldhäusl W J Pharmacol Exp Ther; 2000 May; 293(2):487-93. PubMed ID: 10773019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]